New L.B. Bohle Technology Center Advances Development of Continuous Pharmaceutical Processing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

New L.B. Bohle Technology Center Advances Development of Continuous Pharmaceutical Processing


L.B. Bohle is constructing a technology center next to its service center in Ennigerloh, Germany to provide additional space for developing, testing, and demonstrating continuous-production process equipment for the pharmaceutical industry, the company announced in a press release. Construction started this past August, and the center is expected to open in June 2014.

“Our customers are relying more and more on continuous production,” said company founder Lorenz Bohle, in the press release. “Our technology center will aid in the development of new products that improve the continuous production process because we will be able to visualize entire production lines in one plant using material from wet and dry granulation.”

At the technology center, L.B. Bohle processing experts will work with specialists from the Universities of Dusseldorf and Graz and experts from Siemens to develop new steps for the permanent and interprocess measuring, monitoring, and controlling of the continuous production process. L.B. Bohle will use these developments to produce new equipment and optimize current machinery for use in the pharmaceutical industry.

Source: L.B. Bohle

 

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
27%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns

Click here